AbbVie (ABBV) technical indicators: RSI, moving averages, 52-week range
AbbVie (ABBV) closed at 289.08 USD on 2026-10-20, up 2.26%, the 88th percentile of its daily moves by size since 2013. It is 0.80% below its 52-week high and 51.55% above its 52-week low, and is above its 20-, 50- and 200-day moving averages. Its 20-day return of +9.00% is in the 87th percentile of its history since 2013. AbbVie (ABBV) had an RSI(14) of 71.16 at the 2026-10-20 close, in the 92nd percentile of its history since 2013. At the 2026-10-20 close, the 52-week high of AbbVie (ABBV) was 291.4 USD, set on 2026-10-15, and the 52-week low 190.75 USD, set on 2026-04-29. At the 2026-10-20 close, the 20-day moving average of AbbVie (ABBV) was 272.03 USD. At the 2026-10-20 close, the 50-day moving average of AbbVie (ABBV) was 264.01 USD. At the 2026-10-20 close, the 200-day moving average of AbbVie (ABBV) was 234.52 USD.
Day’s range 285.0–290.98 USD · closed 68.2% of range · width 0.92× ATR52-week low 190.75 (2026-04-29) · high 291.4 (2026-10-15)97.7% of the way from low to high
Today (changed)
RSI 71.2 — crossed above 70 (overbought boundary); Overnight gap +1.49% — 94th percentile
RSI 71.2 — crossed above 70 (overbought boundary): previous same-direction cross 2026-10-16, 2 sessions earlier.
1 state change · 1 notable move
Shifts since 2026-10-19 — two standing rows, then the most unusual shifts against each metric’s own history
| Metric | Prior | Today | Change | Δ vs 2026-10-13 | Move percentile |
|---|---|---|---|---|---|
| RVOL 1.06× | 44th | 67th | +23 pctile pts | — | — |
| MACD histogram | +1.43 | +1.56 | +0.13 | — | — |
| 200-day MA dist | +20.69% | +23.27% | +2.58 pp | +5.59 pp | 90th |
| RSI | 66.26 | 71.16 | +4.90 pts | +9.23 pts | 76th |
The first two rows are always shown and are not ranked; — marks a cell that does not apply.
Follow these changes: RSS feed
Opened up 1.49% from the prior close; closed in the upper half of the day's range, above the prior close.
- ≥2% move today
- 3 sessions since 52-week high
- 85 sessions above 200-day MA
- FOMC in 8d
- Earnings in 10d
- Jobs report in 17d
Unusualness #16/73 (1 = most unusual) (was #36). Its most notable reading: 97.7% of its 52-week range.
Standing distances: RSI 71.16 is 1.16 pts above 70 · price 0.80% (0.4× ATR) below the 52-week high · 51.55% (15.2× ATR) above the 52-week low · 6.27% (2.6× ATR) above the 20-day MA (272.03) · 9.50% (3.9× ATR) above the 50-day MA (264.01) · 23.27% (8.4× ATR) above the 200-day MA (234.52)
Technical assessment
A transparent, rules-based reading of the statistics on this page — informational and educational only, not investment advice or a recommendation to buy or sell. Each scored factor shows the metrics behind it; full numbers are in the sections below.
Factor tally: 4 positive
| Factor | Reading | Summary |
|---|---|---|
| Short-term momentum | 5/10-day returns: +5.37% · +8.40%; MACD +6.65 above signal +5.10; histogram +1.56 (up 0.13 on the previous session). | Improving |
| Medium-term trend | 20/60/120-day returns: +9.00% · +12.52% · +41.78%. | Positive |
| Moving averages | price vs 20/50/200-day MA: +6.27% · +9.50% · +23.27%; stack 20d > 50d > 200d. | Above trend MAs |
| Relative performance | vs the S&P 500 over 20/60/252 days: +9.67% · +8.48% · +10.19%; vs the Nasdaq 100: +12.99% · +7.32% · +7.10%. | Outperforming |
Figures reflect the official regular-session close for 2026-10-20.
Price chart
Price and momentum
- Close
- 289.08 USD
- Daily change
- up 2.26% — 88th percentile by magnitude since 2013 (3470 obs)
- vs market (same day)
- S&P 500 +0.28% · Nasdaq 100 -0.10%
- MACD (12, 26, 9)
- +6.65 (above signal) · signal +5.10 · histogram +1.56 · +0.13 vs 2026-10-19
- 20-day return
- +9.00% — 87th percentile since 2013 (3451 obs) · +7 pctile pts vs 2026-10-19
RSI(14)
- RSI(14)
- 71.16 — 92nd percentile since 2013 (3457 obs) · +4.90 (76th percentile move · +8 pctile pts) vs 2026-10-19 · +9.23 vs 2026-10-13
- RSI last overbought
- today (2026-10-20)
- RSI last oversold
- 215 days ago (2026-03-19)
Session
- Listing
- Exchange: NYSE, Currency: USD
- Open
- 286.9 USD
- High
- 290.98 USD
- Low
- 285.0 USD
- Prior close
- 282.68 USD
- Prior O/H/L
- O 284.23 USD · H 287.93 USD · L 282.59 USD
- Gap (overnight)
- +1.49% — 94th percentile by magnitude since 2013 (3470 obs)
- Intraday (session)
- +0.76%
- Intraday range
- 2.07% of price — 60th percentile since 2013 (3471 obs)
- Close position
- 68.2% of range
- Up days (history)
- 53.7% of 3453 directional sessions (flat days excluded)
- Daily-move distribution
- -2.42% / -0.73% / +0.11% / +0.91% / +2.51% (p5–p95; -7.00 to +7.25 USD at today’s close; 3470 obs)
- ≥4% daily moves
- 0 of last 20 sessions (0%)
Moving averages
| Period | Value | Price vs MA |
|---|---|---|
| 20-day MA | 272.03 USD | +6.27% · +1.90 pp (83rd percentile move since 2013) vs 2026-10-19 · +3.45 pp vs 2026-10-13 · 2.6× its typical daily range (ATR) |
| 50-day MA | 264.01 USD | +9.50% · +2.09 pp (86th percentile move since 2013) vs 2026-10-19 · +4.01 pp vs 2026-10-13 · 3.9× its typical daily range (ATR) |
| 200-day MA | 234.52 USD | +23.27% · +2.58 pp (90th percentile move since 2013) vs 2026-10-19 · +5.59 pp vs 2026-10-13 · 8.4× its typical daily range (ATR) |
| VWAP (20-day) | 273.01 USD | +5.89% |
| VWAP (60-day) | 261.99 USD | +10.34% |
Moving-average trend & crossovers
- 200-day slope (20-session)
- +1.97% · rising
- Price vs 20-day MA
- closed above it for 13 sessions, since 2026-10-02
- Price vs 50-day MA
- closed above it for 29 sessions, since 2026-09-10
- Price vs 200-day MA
- closed above it for 85 sessions, since 2026-06-22
- 20-day / 50-day
- 20-day crossed above 50-day · 2026-05-27 (146 days ago)
- 20-day / 200-day
- 20-day crossed above 200-day · 2026-06-22 (120 days ago)
- 50-day / 200-day
- 50-day crossed above 200-day · 2026-07-09 (103 days ago)
52-week range
- Position
- 97.7% of range
- Drawdown from all-time intraday high
- -0.80% · 5 days ago (2026-10-15)
- Maximum drawdown (10-year, close-basis)
- -48.88% · 2018-01-26 123.21 USD → 2019-08-15 62.98 USD · recovered 2021-12-09
- 52-week high
- 291.4 USD · price -0.80% · 2026-10-15 (5 days ago)
- 52-week low
- 190.75 USD · price +51.55% · 2026-04-29 (174 days ago)
- Fresh 52-week extremes, last 20 sessions
- 7 new highs
Volatility
- 5-day realised volatility
- 1.729% daily · 27.4% annualised — 75th percentile since 2013 (3466 obs)
- 20-day realised volatility
- 1.320% daily · 21.0% annualised — 44th percentile since 2013 (3451 obs) · +5 pctile pts vs 2026-10-19 · +0.32 pp vs 2026-10-13
- 60-day realised volatility
- 1.388% daily · 22.0% annualised — 39th percentile since 2013 (3411 obs)
- 120-day realised volatility
- 1.614% daily · 25.6% annualised — 57th percentile since 2013 (3351 obs)
- Term structure (20d vs 120d)
- 0.82× — 1.32% vs 1.614% (near-term below its longer-horizon baseline)
- ATR (14)
- 6.47 USD · 2.24% of price — 60th percentile since 2013 (3457 obs)
Volume and participation
- Relative volume
- 1.06× prior 20-day average (excl. today) — 67th percentile since 2013 (3451 obs) · +23 pctile pts vs 2026-10-19 · -0.34× vs 2026-10-13
- Volume
- 5.17M shares
- 3-month avg volume (63 sessions)
- 4.84M shares/day
- Dollar volume
- $1.5B — 67th percentile (trailing 252 sessions) · 50th percentile (trailing 20 sessions) · scales with price level; see relative volume above for a price-neutral read
- 20-day avg $ volume
- $1.37B
Short interest and short volume
- Short volume
- 27.5% of reported volume (624K of 2.27M shares; FINRA off-exchange/TRF volume, not the consolidated tape, as of 2026-10-20) · prior 20-session average 45.2% · 5th percentile of the past 252 sessions
Returns
- 5-day
- +5.37% — 93rd percentile since 2013 (3466 obs) · from 274.36 USD on 2026-10-13
- 10-day
- +8.40% — 94th percentile since 2013 (3461 obs) · from 266.69 USD on 2026-10-06
- 20-day
- +9.00% — 87th percentile since 2013 (3451 obs) · from 265.21 USD on 2026-09-22
- 60-day
- +12.52% — 76th percentile since 2013 (3411 obs) · from 256.91 USD on 2026-07-27
- 120-day
- +41.78% — 97th percentile since 2013 (3351 obs) · from 203.89 USD on 2026-04-29
- 252-day
- +25.92% — 71st percentile since 2013 (3219 obs) · from 229.57 USD on 2025-10-17
- Year to date
- +26.52% · from 228.49 USD on 2025-12-31
- Overnight vs intraday (20d)
- overnight +5.69% · intraday +3.13% (compounds to +9.00% total)
- Overnight vs intraday (60d)
- overnight +7.52% · intraday +4.65% (compounds to +12.52% total)
- Overnight vs intraday (252d)
- overnight +9.47% · intraday +15.03% (compounds to +25.92% total)
Market factor
- S&P 500 (52-week)
- beta -0.72 · correlation -0.31
- S&P 500 (26-week)
- beta -1.69 · correlation -0.55
- Nasdaq 100 (52-week)
- beta -0.64 · correlation -0.44
- Nasdaq 100 (26-week)
- beta -0.96 · correlation -0.61
- Health Care (XLV, 52-week)
- beta +1.22 · correlation +0.72
- Health Care (XLV, 26-week)
- beta +1.48 · correlation +0.82
- Health Care (XLV) — this stock's weight, as of 2026-06-30 (quarterly SEC filing)
- 7.7%
- 10Y TIPS real-yield change (52-week)
- correlation -0.14
- 10Y TIPS real-yield change (26-week)
- correlation -0.12
Key dates
- Next earnings
- 2026-10-30 (10 days)
- Next Fed decision (FOMC)
- 2026-10-28 (8 days)
- Next jobs report (BLS)
- 2026-11-06 (17 days)
- Next CPI (BLS)
- 2026-11-10 (21 days)
- Next quarterly index rebalance (S&P 500 & Nasdaq-100)
- 2026-12-18 (59 days) — effective the following trading day
- Next monthly options expiration
- 2026-11-20 (31 days)
- Earnings reaction (realised)
- ±3.59% median 1-day move · 0.15–6.36% range · last 12 reported
- Recent SEC filings
- 8-K 2026-10-15 (Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers) · 10-Q 2026-08-03 · 10-K 2026-02-20 · proxy 2026-03-23 (EDGAR)
- Last ex-dividend
- 2026-10-15, $1.73
Volatility by rate-era
- ZIRP (2009–2015)
- 1.73% (data from 2013-01-02)
- tightening (2015–2018)
- 1.75%
- ZIRP (2019–2021)
- 1.77%
- tightening (2022–2023)
- 1.33%
- easing (2024– )
- 1.60%
Market backdrop: 10Y 5.15% (as of 2026-10-19) · VIX 17.31 (as of 2026-10-20) · dollar 121.40 (as of 2026-10-16) — Treasury curve, real yields, VIX and the dollar
Risk & context
- RSI: Overbought
- Volatility: Normal
- 52-week position: Near 52-week high
- Beta: Low
- Relative volume: Normal
- Earnings: 2026-10-30
What these badges mean
- RSI
- RSI(14) is 71.16. Below 30 oversold, 70 and above overbought; between them neither extreme: 30–45 neutral-low, 45–55 neutral, 55–70 neutral-high. A condition, not a direction.
- Volatility
- 20-day realised volatility at the 44th percentile of its own history since 2013. Higher = larger daily swings; a risk measure, not a direction.
- 52-week position
- Trading at 97.7% of the 52-week range. Position only — being near the high is not itself bullish or bearish.
- Beta
- 52-week beta to the S&P 500 is -0.72. Higher = amplifies market moves; a risk measure, not a direction.
- Relative volume
- Relative volume 1.06x its 20-day average, 67th percentile since 2013. Participation behind the move; not a direction.
- Earnings
- Next scheduled earnings: 2026-10-30 (in 10 days).
Scoring method
- Short-term momentum
- Majority of three votes: the combined 5- and 10-day returns (one vote); MACD against its signal line; the histogram's change on the previous session. A tie reads Mixed.
- Medium-term trend
- Based on the majority sign of the medium-term return horizons.
- Moving averages
- Scored on price vs the 50- and 200-day trend averages.
- Relative performance
- Scored on the majority sign of relative return vs the S&P 500.
Relative performance
This stock’s return minus a benchmark’s over the same window (percentage points; positive = outperformed), at three adjustments: raw vs the index, beta-adjusted excess (isolating the stock-specific move) and vs its sector ETF.
Raw, vs market index
| Relative return | S&P 500 | Nasdaq 100 |
|---|---|---|
| 5-day | +6.56% | +8.85% |
| 10-day | +9.76% | +13.93% |
| 20-day | +9.67% | +12.99% |
| 60-day | +8.48% | +7.32% |
| 252-day | +10.19% | +7.10% |
Beta-adjusted excess
Stock return minus its beta times the index’s return (single-factor approximation, not a causal claim).
| Excess return | S&P 500 | Nasdaq 100 |
|---|---|---|
| 1-day | +2.47% | +2.20% |
| 5-day | +4.51% | +3.13% |
| 10-day | +7.42% | +4.85% |
| 20-day | +8.52% | +6.45% |
| 60-day | +15.43% | +15.85% |
| 252-day | +37.25% | +37.97% |
vs sector ETF (XLV · Health Care)
Return minus the SPDR sector ETF’s (“vs XLV”; positive = outpaced the sector), plus the ETF’s own return.
| Sector return | vs XLV | XLV own |
|---|---|---|
| 1-day | -0.11% | +2.37% |
| 5-day | -0.62% | +5.99% |
| 10-day | +0.78% | +7.62% |
| 20-day | +3.16% | +5.84% |
| 60-day | +2.47% | +10.05% |
| 252-day | +0.41% | +25.51% |
Compared with other stocks
Rank among covered stocks
This stock’s standing on each measure across the covered-stock universe (1 = highest) — a cross-sectional companion to the own-history percentiles above, computed from the same daily dataset. Ranks compare each stock’s current reading; the underlying own-history percentiles draw on histories of differing length (some reaching into coarser early-era pricing), so they are not strictly comparable instrument-to-instrument — read each alongside its own “since YYYY” basis in the table above.
| Measure | Rank |
|---|---|
| 20-day return | 9 of 48 stocks |
| RSI(14) | 8 of 48 stocks |
| 52-week position | 5 of 48 stocks |
| 20-day realised vol | 35 of 48 stocks |
| Relative volume | 12 of 48 stocks |
Of its 4 Health Care peers today: 4 up, 0 down · median +2.66% · AbbVie (ABBV) +2.26% (-0.40 pp vs peer median).
Across the 48 covered stocks today: 29 advancing, 19 declining · 27/48 above their 20-day MA, 25/48 above 50-day, 28/48 above 200-day · median 20-day return -0.60%. AbbVie (ABBV) is above its 20-, 50- and 200-day MAs (20-day return +9.61 pp vs the median stock).
Sector peers — Health Care
| Stock | Same-day | 20-day return | RSI percentile | 52-wk position | Next earnings |
|---|---|---|---|---|---|
| AbbVie (ABBV) | +2.26% | +9.00% | 92nd | 97.7% | 2026-10-30 · 10d |
| Johnson & Johnson (JNJ) | +2.19% | -3.65% | 38th | 77.5% | — |
| Eli Lilly (LLY) | +3.49% | +9.70% | 92nd | 94.6% | 2026-10-29 · 9d |
| UnitedHealth (UNH) | +3.04% | +12.42% | 94th | 79.4% | 2027-01-12 · 84d |
| Pfizer (PFE) | +2.28% | +7.81% | 97th | 97.9% | 2026-11-03 · 14d |
Each stock’s own latest readings for 2026-10-20, from the same daily dataset. 52-week position: 0% at the low, 100% at the high.
Full daily summary
At the 2026-10-20 close, AbbVie (ABBV) traded at 97.7% of its 52-week range. At the 2026-10-20 close, AbbVie (ABBV) had an RSI(14) of 71.16, in the 92nd percentile of its history since 2013. Its 20-day return of +9.00% is in the 87th percentile of its history since 2013. RSI above 70 is conventionally termed overbought. The RSI(14) of AbbVie (ABBV) last entered the overbought zone today (2026-10-20) and the oversold zone 215 days ago (2026-03-19). It is trading above its 20-, 50- and 200-day moving averages. At the 2026-10-20 close, the 20/50/200-day moving averages of AbbVie (ABBV) were 272.03 / 264.01 / 234.52 USD, with price +6.27% / +9.50% / +23.27% against them. Ranked from highest to lowest, its moving averages are the 20-day, 50-day and 200-day. At the 2026-10-20 close, the 52-week range of AbbVie (ABBV) was 190.75–291.4 USD; it closed 0.80% below the high (0.4× its typical daily range) and 51.55% above the low (15.2× its typical daily range). The high was set 5 days ago (2026-10-15) and the low 174 days ago (2026-04-29). At the 2026-10-20 close, AbbVie (ABBV) was 0.80% below its all-time intraday high of 291.4 USD, set 5 days ago (2026-10-15). Its 20-day volatility is 1.320% daily, in the 44th percentile of its history since 2013. Its daily realised volatility is 1.729% over 5 days, 1.320% over 20 days, 1.388% over 60 days and 1.614% over 120 days. Annualised, these are 27.4%, 21.0%, 22.0% and 25.6% respectively. Its 14-day average true range (ATR) is 6.47 USD, 2.24% of price. It has returned +5.37% (93rd percentile since 2013) over 5 days, +8.40% (94th) over 10 days, +9.00% (87th) over 20 days, +12.52% (76th) over 60 days, +41.78% (97th) over 120 days and +25.92% (71st) over 252 days. Against the S&P 500, its weekly returns show a beta of -0.72 and a correlation of -0.31 over 52 weeks; over 26 weeks, a beta of -1.69 and a correlation of -0.55. Relative to the S&P 500, it has returned +6.56% (5-day), +9.76% (10-day), +9.67% (20-day), +8.48% (60-day) and +10.19% (252-day). Its weekly-return correlation with changes in the US 10-year TIPS real yield is -0.14 over 52 weeks and -0.12 over 26 weeks. Next earnings are scheduled for 2026-10-30.
Methodology
This page reports market statistics computed from daily closing data. It states figures and their historical context, and adds a Technical Assessment: a transparent, rules-based reading that puts those same statistics into plain language, including a factor sign tally — a count of how many scored factors read positive, negative or mixed, not a composite score or analyst rating. Every reading follows a fixed, published rule and traces back to the metrics on this page. It is informational and educational only — not investment advice, a price target, a forecast or a recommendation to buy or sell.
Full definitions for every metric on this page — how each is computed, over what window and on what basis — are on the methodology page.
Machine-readable: this page’s numbers and 252-session price history as JSON or the daily close and moving-average series as CSV — the figures above plus the series behind the chart, refreshed each session.
See where AbbVie (ABBV) ranks among today’s most statistically unusual readings on the cross-asset market screener.
See what RSI extremes and other signals have historically been followed by for AbbVie (ABBV) in its measured signal track record.